BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 34439919)

  • 1. Transcriptional Regulation of
    Buist M; Fuss D; Rastegar M
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional Inhibition of the Mecp2 Promoter by MeCP2E1 and MeCP2E2 Isoforms Suggests Negative Auto-Regulatory Feedback that can be Moderated by Metformin.
    Lockman S; Genung M; Sheikholeslami K; Sher AA; Kroft D; Buist M; Olson CO; Toor B; Rastegar M
    J Mol Neurosci; 2024 Jan; 74(1):14. PubMed ID: 38277073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental Autoimmune Encephalomyelitis (EAE)-Induced Elevated Expression of the E1 Isoform of Methyl CpG Binding Protein 2 (MeCP2E1): Implications in Multiple Sclerosis (MS)-Induced Neurological Disability and Associated Myelin Damage.
    Khorshid Ahmad T; Zhou T; AlTaweel K; Cortes C; Lillico R; Lakowski TM; Gozda K; Namaka MP
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28604632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Sensitivity of the Protein Translation Initiation Machinery and mTOR Signaling to
    Buist M; El Tobgy N; Shevkoplyas D; Genung M; Sher AA; Pejhan S; Rastegar M
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.
    Pejhan S; Rastegar M
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MeCP2E1/E2-BDNF-
    Pejhan S; Del Bigio MR; Rastegar M
    Front Cell Dev Biol; 2020; 8():763. PubMed ID: 32974336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel MeCP2 isoform-specific antibody reveals the endogenous MeCP2E1 expression in murine brain, primary neurons and astrocytes.
    Zachariah RM; Olson CO; Ezeonwuka C; Rastegar M
    PLoS One; 2012; 7(11):e49763. PubMed ID: 23185431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain region-specific expression of MeCP2 isoforms correlates with DNA methylation within Mecp2 regulatory elements.
    Olson CO; Zachariah RM; Ezeonwuka CD; Liyanage VR; Rastegar M
    PLoS One; 2014; 9(3):e90645. PubMed ID: 24594659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation, diversity and function of MECP2 exon and 3'UTR isoforms.
    Rodrigues DC; Mufteev M; Ellis J
    Hum Mol Genet; 2020 Sep; 29(R1):R89-R99. PubMed ID: 32681172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Expression and Regulation of Brain-Derived Neurotrophic Factor (BDNF) mRNA Isoforms in Brain Cells from Mecp2(308/y) Mouse Model.
    Rousseaud A; Delépine C; Nectoux J; Billuart P; Bienvenu T
    J Mol Neurosci; 2015 Aug; 56(4):758-767. PubMed ID: 25634725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA Methylation Contributes to the Differential Expression Levels of
    Liyanage VRB; Olson CO; Zachariah RM; Davie JR; Rastegar M
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
    Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential brain region-specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey-white matter variation.
    Pejhan S; Siu VM; Ang LC; Del Bigio MR; Rastegar M
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):735-750. PubMed ID: 32246495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential distribution of the MeCP2 splice variants in the postnatal mouse brain.
    Dragich JM; Kim YH; Arnold AP; Schanen NC
    J Comp Neurol; 2007 Apr; 501(4):526-42. PubMed ID: 17278130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAT-MeCP2 protein variants rescue disease phenotypes in human and mouse models of Rett syndrome.
    Steinkellner H; Kempaiah P; Beribisky AV; Pferschy S; Etzler J; Huber A; Sarne V; Neuhaus W; Kuttke M; Bauer J; Arunachalam JP; Christodoulou J; Dressel R; Mildner A; Prinz M; Laccone F
    Int J Biol Macromol; 2022 Jun; 209(Pt A):972-983. PubMed ID: 35460749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research progress of Rett syndrome causing gene MECP2--the structure, function and modulation of MECP2].
    Zhang JJ; Bao XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Dec; 41(6):712-5. PubMed ID: 20019788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MECP2e1 isoform mutation affects the form and function of neurons derived from Rett syndrome patient iPS cells.
    Djuric U; Cheung AYL; Zhang W; Mok RS; Lai W; Piekna A; Hendry JA; Ross PJ; Pasceri P; Kim DS; Salter MW; Ellis J
    Neurobiol Dis; 2015 Apr; 76():37-45. PubMed ID: 25644311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyl CpG-binding protein isoform MeCP2_e2 is dispensable for Rett syndrome phenotypes but essential for embryo viability and placenta development.
    Itoh M; Tahimic CG; Ide S; Otsuki A; Sasaoka T; Noguchi S; Oshimura M; Goto Y; Kurimasa A
    J Biol Chem; 2012 Apr; 287(17):13859-67. PubMed ID: 22375006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients.
    Lilja T; Wallenborg K; Björkman K; Albåge M; Eriksson M; Lagercrantz H; Rohdin M; Hermanson O
    Epigenetics; 2013 Mar; 8(3):246-51. PubMed ID: 23348913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute intermittent hypoxia-induced expression of brain-derived neurotrophic factor is disrupted in the brainstem of methyl-CpG-binding protein 2 null mice.
    Vermehren-Schmaedick A; Jenkins VK; Knopp SJ; Balkowiec A; Bissonnette JM
    Neuroscience; 2012 Mar; 206():1-6. PubMed ID: 22297041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.